HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Statistics

Total Valuation

TSX:HLS has a market cap or net worth of CAD 146.67 million. The enterprise value is 207.00 million.

Market Cap	146.67M
Enterprise Value	207.00M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:HLS has 31.27 million shares outstanding. The number of shares has decreased by -0.81% in one year.

Current Share Class	31.27M
Shares Outstanding	31.27M
Shares Change (YoY)	-0.81%
Shares Change (QoQ)	-0.75%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	10.73%
Float	19.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.89
PB Ratio	1.71
P/TBV Ratio	n/a
P/FCF Ratio	7.72
P/OCF Ratio	7.62
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.67, with an EV/FCF ratio of 10.89.

EV / Earnings	-10.53
EV / Sales	2.66
EV / EBITDA	8.67
EV / EBIT	n/a
EV / FCF	10.89

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.88.

Current Ratio	1.17
Quick Ratio	0.81
Debt / Equity	0.88
Debt / EBITDA	3.15
Debt / FCF	3.96
Interest Coverage	-0.55

Financial Efficiency

Return on equity (ROE) is -20.02% and return on invested capital (ROIC) is -2.20%.

Return on Equity (ROE)	-20.02%
Return on Assets (ROA)	-1.86%
Return on Invested Capital (ROIC)	-2.20%
Return on Capital Employed (ROCE)	-3.98%
Revenue Per Employee	845,530
Profits Per Employee	-213,748
Employee Count	92
Asset Turnover	0.36
Inventory Turnover	2.13

Taxes

In the past 12 months, TSX:HLS has paid 399,759 in taxes.

Income Tax	399,759
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.54% in the last 52 weeks. The beta is 0.95, so TSX:HLS's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+17.54%
50-Day Moving Average	4.89
200-Day Moving Average	4.99
Relative Strength Index (RSI)	42.28
Average Volume (20 Days)	8,434

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:HLS had revenue of CAD 77.79 million and -19.66 million in losses. Loss per share was -0.63.

Revenue	77.79M
Gross Profit	55.87M
Operating Income	-6.47M
Pretax Income	-19.27M
Net Income	-19.66M
EBITDA	23.82M
EBIT	-6.47M
Loss Per Share	-0.63

Balance Sheet

The company has 15.01 million in cash and 75.34 million in debt, with a net cash position of -60.33 million or -1.93 per share.

Cash & Cash Equivalents	15.01M
Total Debt	75.34M
Net Cash	-60.33M
Net Cash Per Share	-1.93
Equity (Book Value)	86.00M
Book Value Per Share	2.75
Working Capital	5.62M

Cash Flow

In the last 12 months, operating cash flow was 19.26 million and capital expenditures -257,685, giving a free cash flow of 19.00 million.

Operating Cash Flow	19.26M
Capital Expenditures	-257,685
Free Cash Flow	19.00M
FCF Per Share	0.61

Margins

Gross margin is 71.82%, with operating and profit margins of -8.31% and -25.28%.

Gross Margin	71.82%
Operating Margin	-8.31%
Pretax Margin	-24.77%
Profit Margin	-25.28%
EBITDA Margin	30.62%
EBIT Margin	-8.31%
FCF Margin	24.43%

Dividends & Yields

TSX:HLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.81%
Shareholder Yield	0.81%
Earnings Yield	-13.41%
FCF Yield	12.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:HLS has an Altman Z-Score of -0.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.94
Piotroski F-Score	4